SU2C announces three research teams to study gastroesophageal cancer

Mauricio Garcia named Jerome S. Levy, MD, Chair in Gastroenterology and Hepatology at UAMS

The University of Arkansas for Medical Sciences College of Medicine invested Mauricio S. Garcia in the Jerome S. Levy, MD, Chair in Gastroenterology and Hepatology during a May 1 ceremony.

May 10, 2024

Vol.50 No.19

Conversation with The Cancer Letter

Over three years as CEO, Karen Knudsen led ACS through COVID—and reversed the charity’s long slump

Over the past three years, the American Cancer Society has recovered from the fundraising decline brought on by COVID-19 and has reversed the years-long fundraising slump in public support.

Health Canada approves Keytruda for gastroesophageal cancer

Health Canada approved Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the first-line treatment of adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma.

April 26, 2024

Vol.50 No.17

In Brief

AACR recognizes 2023-2024 research grantees

The American Association for Cancer Research has named its newest class of grant recipients.

April 05, 2024

Vol.50 No.14

Clinical Roundup

One in five people with cancer participate in medical research studies, Fred Hutchinson study shows

Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network, and peer institutions released findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least one in five people with cancer, or 21.9%, participate in some form of clinical research.

April 05, 2024

Vol.50 No.14